Search for other works by this author on: ...

This valuable study reports the critical role of two cyclin-dependent kinases, CDK8 and CDK19 ... Spermatogenesis was analyzed by flow cytometry and immunofluorescence (IF) after 2, 8 and 20 weeks ...

Cyclin D1–CDK4/6 phosphorylates GTSE1 in cancer cells, preventing its degradation and sustaining high levels across the cell cycle, which enhances proliferation and correlates with poor prognosis.

Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...

Protein Kinase A ... autophagy-dependent substrate categories included factors involved in protein folding, transport and quality control (Figs. 1B and EV1C). Our pipeline also identified multiprotein ...

Cyclacel Pharmaceuticals, Inc.’s CYCC share price has dipped by 15.89%, which has investors questioning if this is right time to buy.

DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 inhibitor. The report provides product descriptions, patent details, and ...

Cancer drugs that inhibit CDK7 rapidly shut down pathways responsible for cell proliferation within minutes. For organs to ...

Beneath the surface of the tiny, see-through worm Caenorhabditis elegans, researchers have found new clues about how certain ...

Genes in estrogen response pathways are up-regulated and proteins phosphorylated by protein kinase C (PKC) and Cyclin-dependent kinases (CDKs) are aberrantly regulated. We identify aberrant copy ...